| Literature DB >> 22672707 |
Michael Harrison1, Niall M Moyna, Theodore W Zderic, Donal J O'Gorman, Noel McCaffrey, Brian P Carson, Marc T Hamilton.
Abstract
BACKGROUND: Many of the metabolic effects of exercise are due to the most recent exercise session. With recent advances in nuclear magnetic resonance spectroscopy (NMRS), it is possible to gain insight about which lipoprotein particles are responsible for mediating exercise effects.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22672707 PMCID: PMC3393608 DOI: 10.1186/1476-511X-11-64
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Figure 1Fasting very low density lipoprotein-triglyceride (VLDL-TG) in 24 different particle size subfractions in CON, EX-DEF and EX-BAL, determined by nuclear magnetic resonance spectroscopy.
Fasting plasma lipoprotein particle profile in CON, EX-DEF and EX-BAL
| □ Total triglyceride (mg/dL) | 83.9 ± 12.6 | 56.5 ± 6.9 * | 77.1 ± 5.2** |
| | | | |
| □ Total VLDL-TG | 66.6 ± 9.2 | 47.8 ± 5.6 | 58.9 ± 3.8 |
| □ Large VLDL-TG (55–260 nm) | 39.3 ± 8.2 | 24.8 ± 3.6 * | 35.3 ± 2.8** |
| □ Large VLDL-TG (70–120 nm) | 29.3 ± 7.4 | 15.5 ± 3.3 * | 25.6 ± 2.6** |
| □ Medium VLDL-TG | 10.5 ± 1.0 | 5.2 ± 2.3 * | 5.6 ± 1.3 * |
| □ Small VLDL-TG | 16.8 ± 1.4 | 17.8 ± 1.6 | 18.1 ± 2.4 |
| | | | |
| □ Total VLDL | 41.3 ± 3.4 | 37.9 ± 3.5 | 40.5 ± 3.5 |
| □ Large VLDL (55–260 nm) | 4.1 ± 0.8 | 2.2 ± 0.5* | 3.5 ± 0.4** |
| □ Medium VLDL | 7.5 ± 0.7 | 3.7 ± 1.6* | 4.0 ± 0.9* |
| □ Small VLDL | 29.7 ± 2.4 | 32.0 ± 3.1 | 33.0 ± 3.6 |
| | | | |
| Total LDL | 698 ± 64 | 702 ± 49 | 682 ± 56 |
| Large LDL | 205 ± 53 | 235 ± 69 | 175 ± 38 |
| All Small LDL | 299 ± 37 | 297 ± 49 | 312 ± 15 |
| IDL | 194 ± 24 | 170 ± 19 | 195 ± 27 |
| | | | |
| Total HDL | 23.9 ± 0.9 | 24.3 ± 1.4 | 23.9 ± 1.1 |
| Large HDL | 2.2 ± 0.2 | 2.5 ± 0.4 | 2.1 ± 0.31 |
| Medium HDL | 7.4 ± 0.8 | 7.7 ± 1.1 | 6.9 ± 0.97 |
| Small HDL | 14.3 ± 0.5 | 14.0 ± 0.8 | 14.9 ± 1.1 |
| | | | |
| □ VLDL | 51.8 ± 1.8 | 46.0 ± 1.9* | 50.9 ± 1.5** |
| LDL | 20.8 ± 0.2 | 20.7 ± 0.2 | 20.7 ± 0.1 |
| HDL | 9.0 ± 0.1 | 9.1 ± 0.1 | 9.0 ± 0.2 |
Values are mean ± SEM; n = 8. CON, non-exercised control condition. EX-DEF, morning after prolonged exercise without carbohydrate replacement and thus during carbohydrate deficit; EX-BAL, morning after prolonged exercise with sufficient carbohydrate replacement to restore carbohydrate and energy balance following exercise. Large, medium and small VLDL are defined as 55 – 260 nm, 43 – 55 nm and 29 – 43 nm diameters respectively with data also presented for 70 – 120 nm range (subset of large). IDL, large LDL and small LDL are defined as 23 – 27 nm, 21.2 – 23 nm and 18 – 21.2 nm diameters, respectively. Large HDL, medium HDL and small HDL are defined as 8.8 - 13 nm, 8.2 – 8.8 nm and 7.3 – 8.2 nm diameters respectively. Differences assessed using one-way repeated measures ANOVA followed by LSD post-hoc. *p < 0.05 vs CON; **p < 0.05 compared to EX-DEF; □ data log-transformed prior to statistical analysis.
Figure 2Skeletal muscle lipoprotein lipase activity in CON, EX-DEF and EX-BAL.
Association of skeletal muscle lipoprotein lipase activity with lipid and lipoprotein particles in CON, EX-DEF and EX-BAL
| Serum TG (mg/dL) (biochemical) | −0.98* | `-0.36 | −0.56 |
| VLDL-TG (mg/dL) | −0.81* | −0.21 | −0.68 |
| Total VLDL particles (nmol/L) | −0.76* | +0.46 | +0.25 |
| Large VLDL particles (nmol/L) | −0.95* | −0.61 | −0.68 |
| Medium VLDL particles (nmol/L) | −0.24 | −0.36 | −0.25 |
| Small VLDL particles (nmol/L) | −0.86* | +0.93* | +0.29 |
| IDL particles (nmol/L) | −0.57 | −0.14 | −0.21 |
| LDL particles (nmol/L) | −0.41 | +0.14 | −0.18 |
| Small LDL particles (nmol/L) | −0.10 | −0.36 | −0.39 |
| HDL particles (μmol/L) | +0.25 | −0.04 | −0.11 |
| Large HDL particles (nmol/L) | +0.72* | +0.25 | +0.23 |
| Mean VLDL size (nm) | −0.90* | −0.79* | −0.61 |
| Mean HDL size (nm) | +0.90* | +0.38 | +0.05 |
| Mean LDL size (nm) | +0.30 | +0.11 | −0.16 |
*p < 0.05; for definitions see Table 1.